Novartis AG ADR (NVS) Social Stream
NOVARTIS AG (NVS) Price Targets From Analysts
Use the tables below to see what analysts covering NOVARTIS AG think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-27 | 7 | $108 | $100 | $104.333 | $101.54 | 2.75% |
| 2022-01-17 | 8 | $105 | $100 | $102.666 | $101.54 | 1.11% |
| 2022-03-08 | 7 | $105 | $100 | $103 | $101.54 | 1.44% |
| 2022-04-13 | 6 | $105 | $100 | $103 | $101.54 | 1.44% |
| 2022-05-16 | 6 | $106 | $100 | $103.666 | $101.54 | 2.09% |
| 2022-08-26 | 6 | $105 | $97 | $101.666 | $101.54 | 0.12% |
| 2022-09-27 | 7 | $105 | $97 | $101.666 | $101.54 | 0.12% |
| 2022-10-25 | 7 | $105 | $97 | $101 | $101.54 | -0.53% |
| 2022-11-21 | 7 | $105 | $92 | $99.333 | $101.54 | -2.17% |
| 2022-12-05 | 7 | $105 | $101 | $102.666 | $101.54 | 1.11% |
| 2022-12-20 | 7 | $107 | $102 | $104.666 | $101.54 | 3.08% |
| 2023-01-16 | 7 | $108 | $102 | $105 | $101.54 | 3.41% |
| 2023-02-17 | 8 | $108 | $102 | $105 | $101.54 | 3.41% |
| 2023-03-27 | 8 | $108 | $102 | $105 | $101.54 | 3.41% |
| 2023-04-18 | 8 | $113.5 | $105 | $108.833 | $101.54 | 7.18% |
| 2023-04-25 | 8 | $113.5 | $105 | $110.166 | $101.54 | 8.5% |
| 2023-04-26 | 8 | $120 | $105 | $112.333 | $101.54 | 10.63% |
| 2023-07-17 | 8 | $120 | $105 | $114 | $101.54 | 12.27% |
| 2023-07-19 | 8 | $124 | $105 | $115.333 | $101.54 | 13.58% |
| 2023-07-23 | 8 | $124 | $105 | $116.666 | $101.54 | 14.9% |
| 2023-09-05 | 8 | $124 | $105 | $116 | $101.54 | 14.24% |
| 2023-09-12 | 8 | $129 | $105 | $117.666 | $101.54 | 15.88% |
The Trend in the Analyst Price Target
Over the past 12 months, NVS's average price target has gone up $16.
Over the past 48 weeks, NVS's average upside potential has been 16.74%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-05 | 7 | 105.0 | 101 | 102.666 | 90.96 | 12.87% |
| 2023-03-28 | 8 | 113.5 | 105 | 108.833 | 90.95 | 19.66% |
| 2023-07-11 | 8 | 120.0 | 105 | 114.000 | 97.16 | 17.33% |
| 2023-07-23 | 8 | 124.0 | 105 | 116.666 | 105.01 | 11.1% |
| 2023-09-12 | 8 | 129.0 | 105 | 117.666 | 100.66 | 16.89% |
NVS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.25 | 3 | 0 | 5 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
NVS's average broker recommendation rating improved by 0.08 over the prior 17 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, NOVARTIS AG's variance in analysts' estimates is lower than -69.89% of them.
- In the context of stocks in the mega market cap category, NOVARTIS AG's number of analysts covering the stock is higher than 90.01% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, NOVARTIS AG's upside potential (average analyst target price relative to current price) is greater than 224.73% of them.
- In the context of Pharmaceutical Products stocks, NOVARTIS AG's average analyst price target is greater than 1976.79% of them.
Stocks similar to NOVARTIS AG in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ABBV, MRK, and JNJ.
View All Top Stocks by Price Target
Make investment decisions regarding NVS using the data that counts. Try POWR Ratings for free.